Eutilex.Co.,Ltd (KOSDAQ:263050)
South Korea flag South Korea · Delayed Price · Currency is KRW
959.00
+221.00 (29.95%)
At close: Feb 6, 2026

Eutilex.Co.,Ltd Revenue

Eutilex.Co.,Ltd had revenue of 1.25B KRW in the quarter ending March 31, 2026, a decrease of -38.59%. This brings the company's revenue in the last twelve months to 9.51B, down -15.49% year-over-year. In the year 2025, Eutilex.Co.,Ltd had annual revenue of 10.29B with 8.06% growth.

Revenue (ttm)
9.51B
Revenue Growth
-15.49%
P/S Ratio
3.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.32B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202510.29B768.30M8.06%
Dec 31, 20249.53B9.39B7,136.10%
Dec 31, 2023131.65M-84.01M-38.95%
Dec 31, 2022215.66M142.12M193.25%
Dec 31, 202173.54M-1.96B-96.39%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Psomagen60.70B
J2KBIO36.82B
NGeneBio31.20B
ADBiotech12.51B
MOA Life Plus10.45B
HLB Pep5.52B
Quratis1.26B
Kainos Medicine1.17B
Revenue Rankings